Curevo, a Seattle-based biotech startup developing a vaccine against shingles, raised $110 million in a Series B round.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

The pharma will acquire Araris Biotech to gain access to three preclinical ADCs and a linking technology Araris claims is ...

Chinese drug maker Akeso, whose new cancer drug has outperformed a leading Western peer in clinical studies, is being hailed ...

Sutro Biopharma, a Bay Area oncology biotech company, is laying off around half its staff, switching up its leadership team ...

AstraZeneca makes a deal to buy another biotech company, this one with a price tag that could reach $1 billion.

There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.

A new biotech is raising money to develop a drug believed to be capable of starving cancer cells, based on research out of a ...

In this article, we will be taking a look at the 15 best biotech stocks to buy according to billionaires. Although biotech ...

Partex's platform will provide comprehensive analyses, including target identification, indication expansion, and molecular profiling, ultimately accelerating the process of bringing innovative ...

Offering free solutions can generate goodwill and strengthen relationships with both existing and potential customers. When a ...

A St. Louis-based company known for its work in Alzheimer's and neurological testing can expand its footprint, thanks to a ...